Penn State Hershey announces partnership with investor network

The Office of Technology Development at Penn State College of Medicine has entered into a partnership with Keiretsu Forum Mid-Atlantic, the East Coast Region of the world’s largest private equity angel investment network to provide resources and mentoring to early-stage life science technologies.

Keiretsu is a Japanese term which describes a group of affiliated corporations with broad power and reach, and Keiretsu Forum boasts a worldwide network of capital, resources and investments in 26 chapters located across three continents. Keiretsu Forum Mid-Atlantic consists of four chapters in Philadelphia, Pittsburgh, New York City and metro Washington, D.C. Keiretsu Forum focuses on building successful start-up companies through partnerships and access to funding, talent, technology and resources. The group includes investors, business leaders, venture capitalists, corporate and institutional investors, and serial entrepreneurs.

Penn State Hershey faculty and students will have access to resources and mentoring from experienced angel investors to facilitate the translation of research into the next phase of commercialization. A group of investors will meet with Penn State Hershey entrepreneurs each month to help strengthen the commercial potential of the research. Faculty and students will receive guidance on their research, including their investment presentation, potential funding opportunities and time and resources required to move their research to the next stage of commercialization.

“The life science arena is one of the largest investment sectors for Keiretsu Forum Members,” said Howard Lubert, area president of Keiretsu Forum Mid-Atlantic . “The partnership with Penn State Hershey allows our experienced investors to become familiar with Penn State technologies and expand our investment opportunities in the life sciences. The goal of the program is to create a strong commercialization plan and present it to the investment community.”

“The guidance and resources provided through this program is a key component to the successful launch of life science companies” said Keith Marmer, director of the Office of Technology Development and associate dean for research innovation at Penn State College of Medicine. “It is an invaluable opportunity for early stage entrepreneurs to gain feedback from experienced angel investors.”

For more information, visit: med.psu.edu/technologydevelopment or contact the Office of Technology Development at 717-531-8496 or tech_dev_events@hmc.psu.edu.

Contacts: 
Last Updated July 03, 2013